| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Medicine, Divisions of Neurology (Drs. Brey, Navarrete, and Hermosillo–Romo, and A. Saklad, C. Stallworth, C. Valdez, C. Rhine, and P. Padilla) and Clinical Immunology (Drs. Escalante and del Rincón); Audie L. Murphy Veterans Association Hospital (Dr. Holliday), San Antonio, TX; Willford Hall United States Air Force Medical Center (Dr. Gronseth and D. McGlasson), Lackland Air Force Base, TX.
Address correspondence and reprint requests to Dr. Robin L. Brey, Department of Medicine, Division of Neurology, 7703 Floyd Curl Drive #7883, San Antonio, TX 78229-3900; e-mail: brey{at}uthscsa.edu
Objective: The San Antonio Lupus Study of Neuropsychiatric Disease is a longitudinal study designed to characterize the spectrum of and important risk factors for specific neuropsychiatric systemic lupus erythematosus (NPSLE) syndromes.
Methods: Subjects must meet criteria for SLE and must be at least 18 years of age. A standardized medical history, neurologic, rheumatologic, and psychiatric examinations, computerized neuropsychological evaluation, and serologic testing are performed.
Results: This report is based on the first 128 subjects (120 women and 8 men) who completed the initial study visit. Data from this initial study visit were evaluated for the prevalence of NPSLE using the American College of Rheumatology case definitions for 19 NPSLE syndromes. One or more NPSLE syndromes were present in 80% of subjects: cerebrovascular disease (2, 2%; ischemic stroke); headaches (73, 57%); mononeuropathy (9, 8%; median 8, ulnar 1); movement disorder (1, 1%; chorea); neuropathy, cranial (2, 2%; trigeminal); polyneuropathy (29, 22%; sensorimotor); seizures (21, 16%; partial); anxiety disorder (27, 24%); major depressive-like episode (37, 28%); mood disorder with depressive features (21, 19%); mood disorder with manic features (3, 3%); mood disorder with mixed features (1, 1%); psychosis (6, 5%). In a subset of 67 patients who received standardized neuropsychological testing, 21% had normal results. In the remainder, the following levels of impairment were seen: 43% mild, 30% moderate, and 6% severe.
Conclusions: The prevalence of NPSLE was high in this cohort of unselected patients with SLE. Headaches, cognitive dysfunction, and psychiatric disorders were the most common NPSLE syndromes seen. These results will be easily comparable to other studies also using standardized diagnostic criteria. However, the lack of ethnicity and language-matched normative neuropsychological data may make comparisons of cognitive dysfunction in SLE populations difficult.
This article has been cited by other articles:
|
|
 |
|
  M. Blank, Y. Shoenfeld, and A. Perl Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus Lupus, November 1, 2009; 18(13): 1136 - 1143. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Mak, R. C. M. Ho, and C. S. Lau Clinical implications of neuropsychiatric systemic lupus erythematosus Adv. Psychiatr. Treat., November 1, 2009; 15(6): 451 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Harboe, A B Tjensvoll, S Maroni, L G Goransson, O J Greve, M K Beyer, A Herigstad, J T Kvaloy, and R Omdal Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study Ann Rheum Dis, October 1, 2009; 68(10): 1541 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Alao, S. Chlebowski, and C. Chung Neuropsychiatric Systemic Lupus Erythematosus Presenting as Bipolar I Disorder With Catatonic Features Psychosomatics, September 1, 2009; 50(5): 543 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. HANLY, L. SU, V. FAREWELL, G. McCURDY, L. FOUGERE, and K. THOMPSON Prospective Study of Neuropsychiatric Events in Systemic Lupus Erythematosus J Rheumatol, July 1, 2009; 36(7): 1449 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Paran, I Litinsky, I Shapira-Lichter, S Navon, T Hendler, D Caspi, and E Vakil Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test Ann Rheum Dis, June 1, 2009; 68(6): 812 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Zhu, L.-S. Tam, V. W. Y. Lee, K. K. Lee, and E. K. Li Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong Rheumatology, May 1, 2009; 48(5): 564 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hanly The neuropsychiatric SLE SLICC inception cohort study Lupus, December 1, 2008; 17(12): 1059 - 1063. [PDF]
|
|
|
|
 |
|
 P. Verdoot, E. L. Constant, and A. Seghers Neuropsychiatric systemic lupus erythematosus associated with neuroleptic malignant syndrome The British Journal of Psychiatry, December 1, 2008; 193(6): 507 - 508. [Full Text] [PDF]
|
|
|
|
|
|
D Shprecher, T Frech, S Chin, R Eskandari, and J Steffens Progressive multifocal leucoencephalopathy associated with lupus and methotrexate overdose Lupus, November 1, 2008; 17(11): 1029 - 1032. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Pego-Reigosa and D. A. Isenberg Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease Rheumatology, October 1, 2008; 47(10): 1498 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sundquist, J. C. Martineus, X. Li, K. Hemminki, and J. Sundquist Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalizations in Sweden between 1973 and 2004 Rheumatology, August 1, 2008; 47(8): 1199 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sundquist, X. Li, K. Hemminki, and J. Sundquist Subsequent Risk of Hospitalization for Neuropsychiatric Disorders in Patients With Rheumatic Diseases: A Nationwide Study From Sweden Arch Gen Psychiatry, May 1, 2008; 65(5): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Ramsey-Goldman, G. Alarcon, G McGwin, M Petri, L. Vila, J. Edberg, J. Reveille, and R. Kimberly for the PR Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort Lupus, March 1, 2008; 17(3): 177 - 184. [Abstract] [PDF]
|
|
|
|
|
|
M. Nazarinia, F Ghaffarpasand, A Shamsdin, A. Karimi, N Abbasi, and A Amiri Systemic lupus erythematosus in the Fars Province of Iran Lupus, March 1, 2008; 17(3): 221 - 227. [Abstract] [PDF]
|
|
|
|
|
|
H. Zhou, F. Zhang, X. Tian, X. Leng, J. Lu, Y. Zhao, F. Tang, X. Zhang, X. Zeng, Z. Zhang, et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients Lupus, February 1, 2008; 17(2): 93 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 F. G. Joseph, G. A. Lammie, and N. J. Scolding CNS lupus: A study of 41 patients Neurology, August 14, 2007; 69(7): 644 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.M. Benseler and E.D. Silverman Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 564 - 571. [Abstract] [PDF]
|
|
|
|
|
|
J. A Mikdashi Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials Lupus, June 1, 2007; 16(6): 418 - 425. [Abstract] [PDF]
|
|
|
|
 |
|
 M. S Zandi and A. J Coles Notes on the kidney and its diseases for the neurologist J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 444 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kowal, L. A. DeGiorgio, J. Y. Lee, M. A. Edgar, P. T. Huerta, B. T. Volpe, and B. Diamond From the Cover: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment PNAS, December 26, 2006; 103(52): 19854 - 19859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Oroszi, L Lapteva, E Davis, C H Yarboro, T Weickert, T Roebuck-Spencer, J Bleiberg, D Rosenstein, M Pao, P E Lipsky, et al. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus Ann Rheum Dis, October 1, 2006; 65(10): 1330 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C B Schenatto, R M Xavier, M Bredemeier, L V C Portela, A B L Tort, T L Dedavid e Silva, D O Souza, and J C T Brenol Raised serum S100B protein levels in neuropsychiatric lupus. Ann Rheum Dis, June 1, 2006; 65(6): 829 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-T. Tseng, S.-C. Hsieh, C.-T. Shun, K.-L. Lee, C.-L. Pan, W.-M. Lin, Y.-H. Lin, C.-L. Yu, and S.-T. Hsieh Skin denervation and cutaneous vasculitis in systemic lupus erythematosus Brain, April 1, 2006; 129(4): 977 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sofat, O. Malik, and C.S. Higgens Neurological involvement in patients with rheumatic disease QJM, February 1, 2006; 99(2): 69 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Iikuni, H Okamoto, T Yoshio, E Sato, S Kamitsuji, T Iwamoto, S Momohara, A Taniguchi, H Yamanaka, S Minota, et al. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus Ann Rheum Dis, February 1, 2006; 65(2): 253 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Haupt, S Millen, M Janner, D Falagan, R Fischer-Betz, and M Schneider Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study Ann Rheum Dis, November 1, 2005; 64(11): 1618 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. McLaurin, S. L. Holliday, P. Williams, and R. L. Brey Predictors of cognitive dysfunction in patients with systemic lupus erythematosus Neurology, January 25, 2005; 64(2): 297 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Appenzeller, F. Cendes, and L. T.L. Costallat Epileptic seizures in systemic lupus erythematosus Neurology, November 23, 2004; 63(10): 1808 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G Hanly ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables Lupus, November 1, 2004; 13(11): 861 - 864. [Abstract] [PDF]
|
|
|
|
|
|
M A Rabbani, B K Siddiqui, M H Tahir, B Ahmad, A Shamim, S M. Shah, and A Ahmad Systemic lupus erythematosus in Pakistan Lupus, October 1, 2004; 13(10): 820 - 825. [Abstract] [PDF]
|
|
|
|
|
|
P. H. Lee, U. S. Joo, O. Y. Bang, and C. H. Seo Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism Neurology, July 27, 2004; 63(2): 395 - 396. [Full Text] [PDF]
|
|
|
|
|
|
D. D. Mitsikostas, P. P. Sfikakis, and P. J. Goadsby A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth Brain, May 1, 2004; 127(5): 1200 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O Nived, G Sturfelt, M H Liang, and P De Pablo The ACR nomenclature for CNS lupus revisited Lupus, December 1, 2003; 12(12): 872 - 876. [Abstract] [PDF]
|
|
|
|
|
|
J Sastre-Garriga and X Montalban APS and the brain Lupus, December 1, 2003; 12(12): 877 - 882. [Abstract] [PDF]
|
|
|
|
|
|
G Sanna, M L Bertolaccini, and A Mathieu Central nervous system lupus: a clinical approach to therapy Lupus, December 1, 2003; 12(12): 935 - 942. [Abstract] [PDF]
|
|
|
|
|
|
M Bodani and M D Kopelman A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus Lupus, December 1, 2003; 12(12): 947 - 949. [Abstract] [PDF]
|
|
|
|
|
|
S L Holliday, M G Navarrete, D Hermosillo-Romo, C R Valdez, A R Saklad, A Escalante, and R L Brey Validating a computerized neuropsychological test battery for mixed ethnic lupus patients Lupus, September 1, 2003; 12(9): 697 - 703. [Abstract] [PDF]
|
|
|
|
|
|
H I Brunner, O Y Jones, D J Lovell, A M Johnson, P Alexander, and M S Klein-Gitelman Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage Lupus, August 1, 2003; 12(8): 600 - 606. [Abstract] [PDF]
|
|
|
|
|
|
R. L. Brey and M. A. Petri Neuropsychiatric systemic lupus erythematosus: Miles to go before we sleep Neurology, July 8, 2003; 61(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
|
|
A. Afeltra, P. Garzia, A. P. Mitterhofer, M. Vadacca, S. Galluzzo, F. Del Porto, L. Finamore, S. Pascucci, M. Gasparini, B. Lagana, et al. Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies Neurology, July 8, 2003; 61(1): 108 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sanni and M. A Khamashta Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus Lupus, January 1, 2003; 12(1): 1 - 2. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
